Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation - PubMed (original) (raw)
Review
. 2005 Jun 10;306(2):330-5.
doi: 10.1016/j.yexcr.2005.03.018. Epub 2005 Apr 15.
Affiliations
- PMID: 15925588
- DOI: 10.1016/j.yexcr.2005.03.018
Review
Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation
Carl A Gregory et al. Exp Cell Res. 2005.
Abstract
The first non-hematopoietic mesenchymal stem cells (MSCs) were discovered by Friedenstein in 1976, who described clonal, plastic adherent cells from bone marrow capable of differentiating into osteoblasts, adipocytes, and chondrocytes. More recently, investigators have now demonstrated that multi-potent MSCs can be recovered from a variety of other adult tissues and differentiate into numerous tissue lineages including myoblasts, hepatocytes and possibly even neural tissue. Because MSCs are multipotent and easily expanded in culture, there has been much interest in their clinical potential for tissue repair and gene therapy and as a result, numerous studies have been carried out demonstrating the migration and multi-organ engraftment potential of MSCs in animal models and in human clinical trials. This review describes the recent advances in the understanding of MSC biology.
Similar articles
- Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate.
Gregory CA, Ylostalo J, Prockop DJ. Gregory CA, et al. Sci STKE. 2005 Jul 26;2005(294):pe37. doi: 10.1126/stke.2942005pe37. Sci STKE. 2005. PMID: 16046665 Review. - Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR, Volloch V, Kaplan DL. Mauney JR, et al. Biomaterials. 2005 Nov;26(31):6167-75. doi: 10.1016/j.biomaterials.2005.03.024. Biomaterials. 2005. PMID: 15913765 - Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts.
Chen XD, Dusevich V, Feng JQ, Manolagas SC, Jilka RL. Chen XD, et al. J Bone Miner Res. 2007 Dec;22(12):1943-56. doi: 10.1359/jbmr.070725. J Bone Miner Res. 2007. PMID: 17680726 - In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice.
Chou SH, Kuo TK, Liu M, Lee OK. Chou SH, et al. J Orthop Res. 2006 Mar;24(3):301-12. doi: 10.1002/jor.20047. J Orthop Res. 2006. PMID: 16482576 - From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells.
Giordano A, Galderisi U, Marino IR. Giordano A, et al. J Cell Physiol. 2007 Apr;211(1):27-35. doi: 10.1002/jcp.20959. J Cell Physiol. 2007. PMID: 17226788 Review.
Cited by
- Sox2 suppression by miR-21 governs human mesenchymal stem cell properties.
Trohatou O, Zagoura D, Bitsika V, Pappa KI, Antsaklis A, Anagnou NP, Roubelakis MG. Trohatou O, et al. Stem Cells Transl Med. 2014 Jan;3(1):54-68. doi: 10.5966/sctm.2013-0081. Epub 2013 Dec 4. Stem Cells Transl Med. 2014. PMID: 24307698 Free PMC article. - New insights into the properties, functions, and aging of skeletal stem cells.
Rong L, Zhang L, Yang Z, Xu L. Rong L, et al. Osteoporos Int. 2023 Aug;34(8):1311-1321. doi: 10.1007/s00198-023-06736-4. Epub 2023 Apr 18. Osteoporos Int. 2023. PMID: 37069243 Review. - Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions.
de Lourdes Mora-García M, García-Rocha R, Morales-Ramírez O, Montesinos JJ, Weiss-Steider B, Hernández-Montes J, Ávila-Ibarra LR, Don-López CA, Velasco-Velázquez MA, Gutiérrez-Serrano V, Monroy-García A. de Lourdes Mora-García M, et al. J Transl Med. 2016 Oct 26;14(1):302. doi: 10.1186/s12967-016-1057-8. J Transl Med. 2016. PMID: 27782859 Free PMC article. - Intrinsic differentiation potential of adolescent human tendon tissue: an in-vitro cell differentiation study.
de Mos M, Koevoet WJ, Jahr H, Verstegen MM, Heijboer MP, Kops N, van Leeuwen JP, Weinans H, Verhaar JA, van Osch GJ. de Mos M, et al. BMC Musculoskelet Disord. 2007 Feb 23;8:16. doi: 10.1186/1471-2474-8-16. BMC Musculoskelet Disord. 2007. PMID: 17319938 Free PMC article. - Hematopoietic stem cell origin of mesenchymal cells: opportunity for novel therapeutic approaches.
Ogawa M, Larue AC, Watson PM, Watson DK. Ogawa M, et al. Int J Hematol. 2010 Apr;91(3):353-9. doi: 10.1007/s12185-010-0554-4. Epub 2010 Mar 26. Int J Hematol. 2010. PMID: 20336396 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources